Valeant Pharmaceuticals International (VRX) · page 29 of 47
The table uses a weighted average approach (70% * 20.0x + 30% * 8.0x = 16.4x).
Conference presentation · valuation_table · show_valuation_bridge · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
disclaimer 1/1 legend 2/2 paragraph 1/1 table 1/1 title 1/1
Components 6
disclaimer legend legend paragraph valuation headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1